Cargando…

EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise

The receptor for epidermal growth factor (EGFR) is a prime target for cancer therapy across a broad variety of tumor types. As it is a tyrosine kinase, small molecule tyrosine kinase inhibitors (TKIs) targeting signal transduction, as well as monoclonal antibodies against the EGFR, have been investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Westphal, Manfred, Maire, Cecile L., Lamszus, Katrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573763/
https://www.ncbi.nlm.nih.gov/pubmed/28791656
http://dx.doi.org/10.1007/s40263-017-0456-6